Monarch Partners Asset Management’s Integra LifeSciences IART Stock Holding History

Monarch Partners Asset Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-82,608	Closed	-$5.71M	–	163
2021 Q1	$5.71M	Sell	82,608 -4,658	-5%	-$316K	0.86%	57
2020 Q4	$5.67M	Buy	+87,266	New	+$4.7M	0.99%	36
2020 Q1	–	Sell	-6,138	Closed	-$358K	–	175
2019 Q4	$358K	Sell	6,138 -12,802	-68%	-$762K	0.08%	165
2019 Q3	$1.14M	Sell	18,940 -2,237	-11%	-$133K	0.17%	98
2019 Q2	$1.18M	Sell	21,177 -34,525	-62%	-$1.78M	0.17%	86
2019 Q1	$3.1M	Buy	+55,702	New	+$2.84M	0.47%	75

Other funds holding IART

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

EVM

Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Monarch Partners Asset Management's IART Position: Q2 2021 in Review

Monarch Partners Asset Management sold out of Integra LifeSciences (IART) in Q2 2021, closing a stake of 82,608 shares — an estimated $5.71M sold.

Monarch Partners Asset Management first reported a position in IART in Q1 2019 and held it in 6 quarters. The position peaked at $5.71M in Q1 2021. 264 funds tracked by Wall St. Rank hold IART as of Q2 2021.

Monarch Partners Asset Management reported no remaining Integra LifeSciences position as of Q2 2021 after selling out during the quarter.
Monarch Partners Asset Management sold 82,608 Integra LifeSciences shares in Q2 2021, an estimated $5.71M.
Monarch Partners Asset Management first reported a position in Integra LifeSciences in Q1 2019 and held it in 6 quarters.
Monarch Partners Asset Management's Integra LifeSciences position peaked at $5.71M in Q1 2021.
264 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2021.

Based on Monarch Partners Asset Management's 13F filing for Q2 2021, filed 30 Jul 2021.